It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

The knowledge mounting has already helped explain why different patients present different
forms of leishmaniasis and respond differently to treatment, and may be on the verge of …

Recent epidemiologic studies indicate that leishmaniasis in the Americas is far more
abundant and of greater public health importance than was previously recognized. The …

Leishmaniasis: new approaches to disease control | The BMJ Skip to main content Intended
for healthcare professionals Access provided by Google Indexer Subscribe My Account My …

T he diagnosis of leishmaniasis has been relatively static until recent years. Health care
workers in endemic or epidemic areas often rely on clinical evaluation, sometimes combined …

Governed by parasite and host factors and immunoinflammatory responses, the clinical
spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions) …

Leishmaniasis is a global term for cutaneous and visceral anthroponotic and zoonotic
diseases caused by the vector-borne parasites of the genus Leishmania. These diseases …

The World Health Organization estimates that approximately 400,000 new cases of
leishmaniasis occur worldwide each year. Cutaneous leishmaniasis is being encountered …

Bacterial infections are often seen in patients with visceral leishmaniasis. To determine the
incidence ofsuch infection and the more common infectious agents, 30 consecutive patients …

In 2004, visceral leishmaniasis (kala-azar) maintains its status as a neglected, if not “most
neglected” disease. Lack of affordable new drugs, still a basic unsolved problem, has also …